These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 336442)

  • 1. [Clinical experimentation with a new drug lowering blood lipids (Tiadenol)].
    Potì R; Quintavalla R; Manotti C
    G Clin Med; 1977; 58(7-8):293-300. PubMed ID: 336442
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indications and limitations of tiadenol therapy of dyslipidemia in the elderly].
    Passeri M; Cocchi C; Ceccato S; Palummeri E; Cucinotta D
    G Clin Med; 1979 Jan; 60(1):49-64. PubMed ID: 456778
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of tiadenol in prolonged therapy of hyperlipoproteinemias (type IIa-IIb)].
    Rouffy J
    Therapie; 1975; 30(6):815-23. PubMed ID: 785682
    [No Abstract]   [Full Text] [Related]  

  • 4. [A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)].
    Proto C; Quadri A; Ratti S; Levi GF; Prandini BD
    G Ital Cardiol; 1978; 8(7):743-51. PubMed ID: 355033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical experimentation of clofibride. Apropos of 40 cases].
    Warembourg H; Jaillard J
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hyperlipidemia with a new drug, tibric acid].
    Carmena R; González R Florez J; Sanchis J
    Rev Clin Esp; 1976 Jul; 142(2):151-5. PubMed ID: 788065
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trials with Fonlipol. Apropos of 50 cases].
    Warembourg H; Jaillard J
    Lille Med; 1974 Apr; 19(4 Suppl 11):528-31. PubMed ID: 4612282
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the effects of tiadenol in various types of dyslipidemia].
    Saettone G; Cazzani E; Romanò M; Muzio L
    Clin Ter; 1982 May; 101(4):387-93. PubMed ID: 7105643
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia].
    Arteaga A; Foradori A; Eyzaguirre J; Lira P; Vasquez A; Soto S; Alliende ME; Guzman L
    Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy of lipid lowering drugs alone and in combination.
    Hansen PF
    Postgrad Med J; 1975; 51(8):63-5. PubMed ID: 768949
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bis-(hydroxy-2-ethylthyo)-1,10-decano in hyperlipaemic therapy (author's transl)].
    Cucinotta D; Palummeri E; Ceccato S; Passeri M
    G Ital Cardiol; 1977; 7(3):248-64. PubMed ID: 858465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)].
    Fourrier A; Mouton Y
    Lille Med; 1974 Apr; 19(4 Suppl 11):532-7. PubMed ID: 4612283
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy of procetofen (lipanthyl) in hyperlipidemias (author's transl)].
    Stähelin HB; Seiler W; Pult N
    Schweiz Rundsch Med Prax; 1979 Jan; 68(1):24-8. PubMed ID: 760103
    [No Abstract]   [Full Text] [Related]  

  • 14. [The management of hyperlipoproteinemia with Liproreduct].
    Fenster R
    Ther Ggw; 1974 May; 113(5):813-24. PubMed ID: 4603893
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trial of tibric acid, a new hypolipidemic agent].
    Noseda G; Sirtori CR
    Schweiz Med Wochenschr; 1974 Dec; 104(51):1917-22. PubMed ID: 4438990
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of increasing doses of gemfibrozil in hyperlipoproteinaemia.
    Lageder H; Irsigler K
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):71-5. PubMed ID: 798199
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
    Oriente P; Motolese M; Cerqua R; Mancini M
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):348-53. PubMed ID: 4903988
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypolipidaemic effect of xantinol nicotinate: a clinical trial.
    Dhorranintra B; Khunawat P; Patalung BN; Prabhan C
    J Med Assoc Thai; 1983 May; 66(5):269-73. PubMed ID: 6348198
    [No Abstract]   [Full Text] [Related]  

  • 19. [The problem of an antilipemic synergism between the action of nicotinic acid and the sulphated polyanion SP54 (author's transl)].
    Levy H
    Med Klin; 1974 Sep; 69(36):1441-7. PubMed ID: 4280008
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic effects of bezafibrate in hyperlipidemia].
    Kunesová M; Honková M; Zeman M; Mares P; Skorepa J
    Cas Lek Cesk; 1983 May; 122(20):628-31. PubMed ID: 6342789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.